We pride ourselves on being on the pulse of news and information about colon cancer prevention and treatment. Colon Health Alerts are distributed whenever there are timely or relevant updates in the colon cancer world. Through these alerts, we’re arming you with the information you need to be proactive about your health. You can count on us!
On April 13, 2016, Epigenomics announced that the FDA approved Epi proColon, the first and only blood-based colorectal cancer screening test. This test has the potential to increase participation rates in colorectal cancer screening by providing another option to get checked. How exactly does the test work? The test detects a marker in blood plasma […]
The FDA has approved the use of Lonsurf as a treatment for metastatic colorectal cancer. This new drug gives patients another treatment option when they stop responding to other chemotherapy or biologic treatments. What is Lonsurf? Lonsurf is an oral chemotherapy drug available by prescription for treatment of metastatic colorectal cancer. Lonsfurf is a nucleoside-analogue […]
Eli Lilly and Company recently announced that the FDA has approved the use of Cyramza with FOLFIRI as a second-line treatment for colorectal cancer. This treatment, previously approved for use with advanced or metastatic gastric and lung cancer, now provides metastatic colorectal cancer patients with another biologic to use in the fight against their disease. […]
This week, the U.S. Food and Drug Administration (FDA) approved Cologuard, the first stool-based colon screening test that detects the presence of blood and altered DNA that may indicate certain kinds of abnormal growths related to colon cancer or precursors to cancer. In a study of 10,000 people of average risk for colon cancer, Cologuard […]
Amgen recently announced that the FDA has approved the use of Vectibix as a first-line treatment for colorectal cancer. Since 2006, Vectibix has been used as a second-line treatment and with this recent advancement, colorectal cancer patients now have an additional treatment option earlier in their diagnosis.
A colonoscopy remains the best available procedure for detecting and removing pre-cancerous polyps; however, due to both technique and viewing area, studies have shown that some polyps may be missed. EndoChoice has developed a new colonoscope called Full Spectrum Endoscopy™ (Fuse™) that uses multiple cameras to create a panoramic view, allowing GIs to see more […]
Today, Given Imaging Ltd announced that the U.S. Food and Drug Administration (FDA) has cleared PillCam® COLON as a new way to view the colon. The Colon Cancer Alliance welcomes PillCam COLON as an additional colon exam choice. When detected early, colon cancer is largely preventable. Through advancements like this, we’re one step closer to fulfilling […]